Biologic Agents Show Reliability in Nasal Reconstruction, Including High-Risk Patients

Advancing Nasal Reconstruction: Biologic Agents in Challenging Cases

Reconstruction of nasal defects, frequently resulting from skin malignancy excision, presents a dual challenge of restoring aesthetic form and preserving respiratory function [1, 2]. While local flaps and skin grafts are established techniques, patient comorbidities such as advanced age, smoking, or anticoagulation therapy can increase complication rates and compromise outcomes [3, 4]. This clinical reality drives the search for reliable reconstructive options suitable for higher-risk patient populations. A recent retrospective study now provides specific data on the performance of biologic agents as an alternative to multi-stage procedures in this context.

Study Design and Patient Cohort Characteristics

To evaluate the utility of biologic agents in this setting, researchers conducted a retrospective review of procedures performed by a single surgeon (J.F.T.) between 2013 and 2023. The study analyzed outcomes for patients whose nasal defects were repaired using Integra or ACell, which are acellular biologic scaffolds that provide a matrix for the patient's own cells to regenerate tissue. The investigators collected data on patient demographics, defect characteristics, revisions, and complications to build a comprehensive performance profile. The final cohort included a total of 138 patients. Analysis of the defects showed the ala was the most commonly affected nasal subunit (25.4 percent), a finding consistent with its high sun exposure and frequent site of skin cancer. The mean defect size was 6.9 cm². Of the two agents, ACell was the more frequently used biologic, employed in 73.2 percent of cases.

Complication Profile and Safety in Diverse Patient Groups

A key focus of the investigation was the safety and complication profile associated with these biologic agents. The study found an overall complication rate of 6.5 percent (n = 9) across the 138-patient cohort. These events included issues such as scar retraction, where the healing tissue contracts and distorts the nasal contour, and complete biologic loss, which signifies a failure of the implanted scaffold to integrate with the patient's tissue. Critically for daily practice, the analysis revealed that these complication rates were not elevated in traditionally high-risk groups. The researchers reported no statistically significant differences in complication rates for patients over 75 years of age, those with a history of cigarette smoking, or individuals on anticoagulation therapy. Furthermore, the complication rate was not significantly influenced by defect size or anatomical location on the nose, suggesting a consistent safety profile across a range of clinical scenarios.

Clinical Implications for Nasal Defect Repair

The findings from this review suggest that biologic agents represent a clinically valuable alternative to more complex, multi-staged reconstructive procedures for nasal defects. For the practicing surgeon, this approach offers a simpler, single-stage option that may reduce operative time and patient morbidity compared to local flaps that require a greater degree of surgical dissection. The study's data support the reliability of this technique, demonstrating a low overall complication rate of 6.5 percent. The most significant clinical implication, however, is the consistent performance in high-risk populations. The evidence that complication rates did not increase for elderly patients, smokers, or those on anticoagulants provides a degree of confidence for using these agents in individuals who might otherwise be poor candidates for more extensive surgery. This allows for effective reconstruction across a broader patient demographic, potentially simplifying treatment planning for challenging nasal defects.

References

1. Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nature Reviews Disease Primers. 2020. doi:10.1038/s41572-020-00224-3

2. Hollier PC, Parham MJ, Layon SA, Thornton JF. Reconstruction of Small Nasal Defects. Seminars in Plastic Surgery. 2024. doi:10.1055/s-0044-1795098

3. Al-Bashaireh AM, Haddad LG, Weaver MT, Kelly DL, Xing C, Yoon SL. The Effect of Tobacco Smoking on Musculoskeletal Health: A Systematic Review. Journal of Environmental and Public Health. 2018. doi:10.1155/2018/4184190

4. Breijyeh Z, Karaman R. Comprehensive Review on Alzheimer’s Disease: Causes and Treatment. Molecules. 2020. doi:10.3390/molecules25245789